Viewing Study NCT07129993

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:06 AM
Ignite Modification Date: 2026-02-04 @ 6:20 AM
Study NCT ID: NCT07129993
Status: RECRUITING
Last Update Posted: 2025-12-24
First Post: 2025-08-12
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma
Sponsor: Daiichi Sankyo
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Urothelial Cancer View
None Bladder Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Urothelial Carcinoma View
None Dato-DXd View
None TROPION View
None DS-1062a View
None Datopotamab Deruxtecan View